Research News

Research News | Jan. 07, 2011

Epratuzumab is Safe and Effective for Treatment of Lupus in Phase II Trials

Epratuzumab is an investigational agent for the treatment of lupus. The researchers hoped to learn whether epratuzumab could be a safe and effective treatment for people with moderate-to-severe lupus.

Research News | Jan. 07, 2011

CellCept® Is Superior to Azathioprine In Treatment of Lupus Nephritis

There are a number of treatments used for lupus nephritis, but none of them are approved by the U.S. Food and Drug Administration (FDA). The researchers hoped to compare the efficacy and safety of MMF and azathioprine as maintenance therapy.

Research News | Jan. 07, 2011

Belimumab Allows For Reduction in Steroid Use for People with Lupus

The researchers hoped to learn whether treatment with belimumab could reduce the use of steroids in people with active lupus.

Research News | Nov. 04, 2010

Use of Hydroxychloroquine Benefits Sugar Metabolism in Women With Lupus

The researchers hoped to learn whether there are any tests that could predict low blood sugar in women with lupus taking hydroxychloroquine.

Research News | Aug. 18, 2010

A Self-Assessed Lupus Organ Damage Instrument

The researchers hoped to learn whether a lupus damage questionnaire, filled out by lupus patients instead of their doctors, would be accurate and/or useful.

Research News | Aug. 18, 2010

Hydroxycholoroquine May Protect Against Skin Involvement in Lupus

The researchers hoped to learn what factors have an impact on how much time it takes for a lupus patient to develop skin damage.

Research News | Aug. 18, 2010

Anti-malarial Drugs Decrease Risk of Blood Clots in People with Lupus

The researchers hoped to determine the risk of developing blood clots in people with lupus, while factoring in the year of diagnosis and disease severity.

Research News | Jul. 20, 2010

An Exploration Study of Umbilical Cord Stem Cell Treatment in Lupus

The researchers hoped to determine whether umbilical cord stem cells could be given safely to people with severe and treatment-resistant lupus, and whether this might help to treat lupus.